James Bruno

Advisor at Zenopharm

Mr. Bruno has over thirty years of experience in developing commercial processes for the manufacturing of intermediates and APIs globally. He is the CMC consultant for Zenopharm and provides oversight on the CMC package for IND filing.


Org chart

This person is not in the org chart


Teams

This person is not in any teams


Offices

This person is not in any offices


Zenopharm

Zenopharm is a startup pharmaceutical company founded in 2012 to commercialize innovative oncology therapeutics based on its patented platform technology. Zenopharm is developing transformational therapeutic solutions for the treatment of advanced or metastatic breast cancer.


Industries

Employees

1-10

Links